-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D1lTPKtjiGtt1nCxDd10PwB9dFduNwNzLTYlE/SRTjPUtyo/4eyXTCvFg7cB28j5 hqIloY1NlUeaBZmooBF7Lg== 0000903893-97-000142.txt : 19970225 0000903893-97-000142.hdr.sgml : 19970225 ACCESSION NUMBER: 0000903893-97-000142 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970204 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AVIRON CENTRAL INDEX KEY: 0000949173 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 770309686 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-47823 FILM NUMBER: 97517794 BUSINESS ADDRESS: STREET 1: 297 N BERNARDO AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 4159196500 MAIL ADDRESS: STREET 1: 297 NORTH BERNARDO AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ABINGWORTH BIOVENTURES SICAV CENTRAL INDEX KEY: 0000895906 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 231 VAL DES BONS MALADES L-2121 CITY: LUXEMBERG-KIRCHBERG STATE: N4 BUSINESS PHONE: 3524389891 MAIL ADDRESS: STREET 1: 231 VAL DES BONS MALADES STREET 2: BOITE POSTALE 566 L2015 CITY: LUXEMBOURG STATE: N4 SC 13G 1 SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ___)* Aviron - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.01 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 05376210 --------------------- (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 pages - -------------------------------------------------------------------------------- CUSIP NO. 05376210 13G PAGE 2 OF 5 PAGES ----- ----- - -------------------------------------------------------------------------------- - ------- ------------------------------------------------------------------------ 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Abingworth Bioventures SICAV - ------- ------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)[ ] (b)[ ] - ------- ------------------------------------------------------------------------ 3 SEC USE ONLY - ------- ------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION Luxembourg - ------------------------- ----- ------------------------------------------------ 5 SOLE VOTING POWER NUMBER OF 629,629 ----- ------------------------------------------------ SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY - 0 - ----- ------------------------------------------------ EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 629,629 ----- ------------------------------------------------ WITH 8 SHARED DISPOSITIVE POWER - 0 - - ------- ------------------------------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 629,629 - ------- ------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*[ ] - ------- ------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.5% - ------- ------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON * CO - ------- ------------------------------------------------------------------------ *SEE INSTRUCTIONS BEFORE FILLING OUT! Page 2 of 5 pages ITEM 1(A). Name of Issuer: Aviron ITEM 1(B). Address of Issuer's Principal Executive Offices: 297 North Bernardo Avenue, Mountain View, CA 94043 ITEM 2(A). Name of Person Filing: Abingworth Bioventures SICAV ("ABS") ITEM 2(B). Address of Principal Business Office or, if None, Residence: The address of the principal business office of ABS is 231 Val des Bons Malades, L-2121 Luxembourg-Kirchberg. ITEM 2(C). Citizenship: ABS is a corporation organized under the laws of Luxembourg. ITEM 2(D). Title of Class of Securities: Common Stock, $.01 par value. ITEM 2(E). CUSIP Number: 05376210 ITEM 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) [ ] Broker or Dealer registered under Section 15 of the Securities Exchange Act of 1934 (the "Act"). (b) [ ] Bank as defined in Section 3(a)(6) of the Act. (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act. (d) [ ] Investment Company registered under Section 8 of the Investment Company Act of 1940. (e) [ ] Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940. (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see Rule 13d-1(b)(1)(ii)(F) of the Act. (g) [ ] Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G) of the Act. (h) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(H) of the Act. Not applicable. This statement on Schedule 13G is not filed pursuant to Rule 13d-1(b) or Rule 13d-2(b). Page 3 of 5 pages ITEM 4. Ownership. (a) Amount Beneficially Owned: ABS is the record and beneficial owner of 629,629 shares of Common Stock as of December 31, 1996. (b) Percent of Class: 5.5%. The foregoing percentage is calculated based on the 11,447,382 shares of Common Stock reported to be outstanding in the Quarterly Report on Form 10-Q of Aviron for the quarter ended September 30, 1996. (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 629,629 shares. (ii) shared power to vote or to direct the vote: 0 shares. (iii) sole power to dispose or to direct the disposition of: 629,629 shares. (iv) shared power to dispose or to direct the disposition of: 0 shares. ITEM 5. Ownership of Five Percent or Less of a Class. Not applicable. ITEM 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. ITEM 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. ITEM 8. Identification and Classification of Members of the Group. Not applicable ITEM 9. Notice of Dissolution of Group. Not applicable. ITEM 10. Certification. Not applicable. This statement on Schedule 13G is not filed pursuant to Rule 13d-1(b). Page 4 of 5 pages SIGNATURE After reasonable inquiry and to the best its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: February 4, 1997 ABINGWORTH BIOVENTURES SICAV By: /s/ Karl U. SANNE ------------------------- Name: Karl U. SANNE Title: Director By: /s/ Fernand HEIM ------------------------- Name: Fernand HEIM Title: Mandatory -----END PRIVACY-ENHANCED MESSAGE-----